Company information
- Ticker
- EDXC
- Country
- United States
- Sector
- Health Care
- Industry
- Pharma
Endexx Business Summary
Endexx Corp (EDXC) is a diversified specialty pharmaceutical and consumer wellness company that generates revenue through the development, manufacturing, and global distribution of plant-based health products. The company operates primarily through two flagship segments: CBD Unlimited, which provides hemp-derived oils, topicals, and pet wellness products, and HYLA, a high-growth division specializing in organic, nicotine-free, plant-based vape devices. Revenue streams are diversified across wholesale distribution to approximately 18,000 retail locations, traditional brick-and-mortar retail partnerships—such as its 2024 expansion into American Shaman stores—and a robust direct-to-consumer (DTC) e-commerce platform launched in late 2024 to capture higher margins. In a competitive landscape featuring peers like Elixinol Wellness, CV Sciences, and Charlotte’s Web, Endexx distinguishes itself by pivoting aggressively toward the nicotine-free alternative market, positioning HYLA as a premium, clean-ingredient leader in the rapidly evolving global vaping and botanical wellness sectors. The company’s leadership is currently spearheaded by Interim CEO Brad Listermann, a seasoned strategist and Navy veteran with a background in investment banking (NetStreet Financial) and international film production (WorldFlix). Listermann is supported by Fractional CFO Doug Williams, a CPA and partner at Alexander & Williams with extensive expertise in public company audits and financial reporting. Founder Todd Davis remains a pivotal figure, serving as a board member and CEO of the CBD Unlimited subsidiary to maintain brand continuity. Strategic direction is heavily influenced by Director Claude Zdanow, a marketing visionary and CEO of ONAR Holdings known for founding the Grammy-winning Stadiumred Group, and Board Member Elton Johnson Jr., a decorated Lieutenant Colonel and founder of AmeriVet Securities. This leadership team is currently focused on a strategic transformation aimed at maximizing HYLA’s international footprint and improving financial transparency to drive long-term shareholder value.